Concepedia

Bertrand Nyuykonge

BN

Statistics

Publications

10

Citations

180

H-Index

10

Active since

2020

Affiliations

Erasmus MC(Current)

University of Khartoum

Drugs for Neglected Diseases Initiative

Hospital General de México

Kenya AIDS Vaccine Initiative

Bertrand Nyuykonge is an author at Erasmus MC specializing in drug resistance, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2020–2022

10

Publications

10

Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma

Wilson Lim, Bertrand Nyuykonge, Kimberly Eadie et al. · PLoS neglected tropical diseases · 2022 · 36 citations · Full text

, , +14

Diagnostic implications of mycetoma derived from <i>Madurella pseudomycetomatis</i> isolates from Mexico

Bertrand Nyuykonge, Corné H. W. Klaassen, Willemien H. A. Zandijk et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 20 citations · Full text

The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach

Wilson Lim, Emmanuel Edwar Siddig, Kimberly Eadie et al. · PLoS neglected tropical diseases · 2020 · 20 citations · Full text

Mycetoma caused by<i>Microascus gracilis:</i>a novel agent of human eumycetoma in Sudan

Najwa A. Mhmoud, Emmanuel Edwar Siddig, Bertrand Nyuykonge et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021 · 19 citations · Full text

Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole

Bertrand Nyuykonge, Wilson Lim, Lukas van Amelsvoort et al. · Mycoses · 2022 · 19 citations · Full text

1–5 of 10